Recent news and analysis on Cardiovascular Disease
Cardiovascular news covering heart disease, stroke, blood pressure, cholesterol, and cardiac treatment advances.
The US FDA accepted a supplemental New Drug Application and granted Priority Review to Bristol Myers Squibb's Camzyos (mavacamten) for symptomatic obstructive hypertrophic cardiomyopathy in adolescents. If approved, it would be the first cardiac myosin inhibitor for this condition.
A cardiologist argues that certain foods, such as processed meats and sugary drinks, are particularly harmful to heart health, while also admitting that he personally still enjoys dark chocolate in moderation. The commentary suggests that small indulgences can be part of a balanced diet.